Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PRDX1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
NBPF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
LRRN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BCL9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DUSP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HTATIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BRD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AUTS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IDS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NSFL1C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMYD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSMD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSMB4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CRIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLEKHA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on